Provider Professional Development
Fred Hutchinson Cancer Center provides symposiums, webinars and other educational programs about specific disease programs focusing on advancements to diagnostic techniques and treatment modalities. Our programs feature physician speakers from Fred Hutch, UW Medicine and Seattle Children’s.
What We Do
We support Fred Hutch’s mission of advancing the standard of oncology care throughout the region by providing high quality medical education to healthcare providers. Our oncology-specific education services focus on current and emerging standards of care and treatment options along the cancer care continuum with the goal of improving patient outcomes.
Immune-Related Adverse Events — a Series of Panels Exploring the Side Effects of Immunotherapy
Immune-Related Adverse Events (irAEs), provider-focused discussions on immunotherapy-related treatment, research updates and clinical challenges.
The 90-minute sessions are approximately half didactic information presented by experts in the field and half panel case discussion and questions. Series co-chaired by Shailender Bhatia, MD and Petros Grivas, MD, PhD.
Accreditation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Washington School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit.)
irAEs Panel Series Presentations
Panel 1 Topic: Immune-Related GI Toxicity: updates and clinical dilemma
Recorded on April 24, 2021. Guest speaker is Yinghong (Mimi) Wang, MD, PhD, Associate Professor at MD Anderson Cancer Center.
Panel 2 Topic: Immune-Mediated Pneumonitis
Recorded on June 26, 2021. Guest speaker is Jarushka Naidoo, M.B.B.Ch, Assistant Professor of Oncology at Johns Hopkins.
Panel 3 Topic: Rheumatologic irAEs
Recorded on October 9, 2021. Guest speaker is Maria Suarez-Almazor, MD, PhD, Barnts Family Distinguished Professor at MD Anderson Cancer Center.
Panel 4 Topic: Renal irAEs: Nephrotoxicity of Immune Checkpoint Inhibitors
Recorded on January 29, 2022. Guest speaker is Shruti Gupta, MD, MPH, Director of Onco-Nephrology, Division of Renal Medicine, Brigham and Women’s Hospital/Dana-Farber Cancer Institute.
Panel 5 Topic: ICI-induced Myocarditis
Recorded April 8, 2022. Guest Speaker is Tomas Neilan, MD, MPH Director, Cardio-Oncology Program and Co-Director, Cardiac MR PET CT Program at Massachusetts General Hospital.
Panel 6 Topic: Immune-Related Adverse Events (IrAEs) – a Series of Panels Exploring the Side Effects of Immunotherapy
Recorded on September 23, 2022. Guest speaker is Mario E. Lacouture, MD, Professor and Director, Oncodermatology Program, Dermatology Service, Department of Medicine at Memorial Sloan-Kettering Cancer Center.
Panel 7 Topic: Endocrine irAEs
Recorded on March 10th, 2023. Guest speaker is Melissa G. Lechner, MD, PhD, Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at the UCLA David Geffen School of Medicine.
Panel 8 Topic: Neuro irAEs
Recorded September 8, 2023. Guest Speaker is Bianca D. Santomasso, MD, PhD, Assistant Attending, Department of Neurology and Brain Tumor Center Memorial Sloan Kettering Cancer Center, Assistant Professor of Neurology, Weill Cornell Medical College
Note: During the video, there are slight audio issues starting at 59 seconds and ending at 1 minute, 55 seconds on the timeline. The audio resumes with our featured speaker, Dr. Santomasso.
On-Demand Courses
14th Annual In-Person Comprehensive Hematology & Oncology Review Course
On-demand course available to purchase starting December 1, 2023.
This in-person educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows and covers data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.
13th Annual Comprehensive Hematology and Oncology Review Course
On-demand course available December 1, 2022 – November 30, 2023
This educational program will cover data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.